TR200000384T2 - Oligonükleotitlerin çözelti fazlı sentezi. - Google Patents

Oligonükleotitlerin çözelti fazlı sentezi.

Info

Publication number
TR200000384T2
TR200000384T2 TR2000/00384T TR200000384T TR200000384T2 TR 200000384 T2 TR200000384 T2 TR 200000384T2 TR 2000/00384 T TR2000/00384 T TR 2000/00384T TR 200000384 T TR200000384 T TR 200000384T TR 200000384 T2 TR200000384 T2 TR 200000384T2
Authority
TR
Turkey
Prior art keywords
oligonucleotides
solution
phase synthesis
oligonucleotide
provides
Prior art date
Application number
TR2000/00384T
Other languages
English (en)
Turkish (tr)
Inventor
Bernard Reese Colin
Song Quanlai
Original Assignee
Avecia Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Avecia Limited filed Critical Avecia Limited
Publication of TR200000384T2 publication Critical patent/TR200000384T2/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/301,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • C07D265/321,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings with oxygen atoms directly attached to ring carbon atoms
    • C07D265/33Two oxygen atoms, in positions 3 and 5
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/46Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
    • C07D207/48Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/16Esters of thiophosphoric acids or thiophosphorous acids
    • C07F9/165Esters of thiophosphoric acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/16Esters of thiophosphoric acids or thiophosphorous acids
    • C07F9/165Esters of thiophosphoric acids
    • C07F9/18Esters of thiophosphoric acids with hydroxyaryl compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H11/00Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof
    • C07H11/04Phosphates; Phosphites; Polyphosphates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06Pyrimidine radicals
    • C07H19/10Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16Purine radicals
    • C07H19/20Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/04Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
TR2000/00384T 1997-08-13 1998-08-10 Oligonükleotitlerin çözelti fazlı sentezi. TR200000384T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9717158.1A GB9717158D0 (en) 1997-08-13 1997-08-13 Solution synthesis of oligonucleotides and their phosphorothioate analogues

Publications (1)

Publication Number Publication Date
TR200000384T2 true TR200000384T2 (tr) 2000-11-21

Family

ID=10817430

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/00384T TR200000384T2 (tr) 1997-08-13 1998-08-10 Oligonükleotitlerin çözelti fazlı sentezi.

Country Status (21)

Country Link
US (3) US6506894B1 (enExample)
EP (2) EP1325927A3 (enExample)
JP (1) JP2001515086A (enExample)
KR (1) KR20010022840A (enExample)
CN (1) CN1231492C (enExample)
AT (1) ATE236916T1 (enExample)
BR (1) BR9811166A (enExample)
CA (1) CA2300874A1 (enExample)
DE (1) DE69813243T2 (enExample)
DK (1) DK1003758T3 (enExample)
EA (1) EA003091B1 (enExample)
ES (1) ES2197491T3 (enExample)
GB (1) GB9717158D0 (enExample)
HU (1) HUP0002684A3 (enExample)
IL (1) IL134517A (enExample)
IN (1) IN190784B (enExample)
NO (1) NO20000690L (enExample)
NZ (1) NZ502684A (enExample)
PL (1) PL338888A1 (enExample)
TR (1) TR200000384T2 (enExample)
WO (1) WO1999009041A2 (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9924285D0 (en) * 1999-10-14 1999-12-15 Avecia Ltd Process
GB0004889D0 (en) * 2000-03-01 2000-04-19 Avecia Ltd Synthesis of oligonucleotides
AU2002339175A1 (en) * 2001-11-21 2003-06-10 Avecia Biotechnology Inc. Coupling reagent for h-phosphonate chemistry
JP2005518451A (ja) * 2002-02-22 2005-06-23 ハネウェル・インターナショナル・インコーポレーテッド ホスフィチル化化合物を製造する方法
GB0209539D0 (en) * 2002-04-26 2002-06-05 Avecia Ltd Monomer Polymer and process
WO2005077966A1 (en) * 2004-02-10 2005-08-25 Isis Pharmaceuticals, Inc. Substituted pixyl protecting groups for oligonucleotide synthesis
SG171914A1 (en) 2008-12-02 2011-07-28 Chiralgen Ltd Method for the synthesis of phosphorus atom modified nucleic acids
US8272150B2 (en) * 2008-12-12 2012-09-25 Speedplay, Inc. Shoe sole mounting standard for bicycle cleat
JP2012513450A (ja) 2008-12-23 2012-06-14 ギリンダス・アメリカ・インコーポレイテッド 硫化剤およびオリゴヌクレオチドを合成するためのその使用
SG10201403841QA (en) 2009-07-06 2014-09-26 Ontorii Inc Novel nucleic acid prodrugs and methods of use thereof
CN103298823A (zh) 2010-06-30 2013-09-11 集润德斯股份公司 一种使用n-硫代化合物用于寡核苷酸合成的新方法
DK2620428T3 (da) 2010-09-24 2019-07-01 Wave Life Sciences Ltd Asymmetrisk hjælpegruppe
EP2734208B1 (en) 2011-07-19 2017-03-01 Wave Life Sciences Ltd. Methods for the synthesis of functionalized nucleic acids
WO2013017469A1 (en) 2011-07-29 2013-02-07 Girindus America, Inc. Sulfurization reagents on solid supports
SG11201500243WA (en) 2012-07-13 2015-04-29 Shin Nippon Biomedical Lab Ltd Chiral nucleic acid adjuvant
JP6453212B2 (ja) 2012-07-13 2019-01-16 ウェイブ ライフ サイエンシズ リミテッドWave Life Sciences Ltd. キラル制御
CN104684893B (zh) 2012-07-13 2016-10-26 日本波涛生命科学公司 不对称辅助基团
WO2014085471A1 (en) * 2012-11-28 2014-06-05 Prognosdx Health, Inc. Acid-activated compositions for the treatment of cancers, methods of their use and methods of their preparation
US10144933B2 (en) 2014-01-15 2018-12-04 Shin Nippon Biomedical Laboratories, Ltd. Chiral nucleic acid adjuvant having immunity induction activity, and immunity induction activator
US10322173B2 (en) 2014-01-15 2019-06-18 Shin Nippon Biomedical Laboratories, Ltd. Chiral nucleic acid adjuvant having anti-allergic activity, and anti-allergic agent
US10149905B2 (en) 2014-01-15 2018-12-11 Shin Nippon Biomedical Laboratories, Ltd. Chiral nucleic acid adjuvant having antitumor effect and antitumor agent
MX2016009290A (es) 2014-01-16 2017-02-28 Wave Life Sciences Ltd Diseño quiral.
WO2018215049A1 (en) * 2017-05-23 2018-11-29 F. Hoffmann-La Roche Ag Process for galnac oligonucleotide conjugates

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3444300A (en) * 1964-05-05 1969-05-13 Chevron Res N-polyhaloalkylthio compounds as fungicidal agents
FR1519704A (fr) * 1967-02-14 1968-04-05 Roussel Uclaf Nouveaux composés dithiocarbamiques hétérocycliques et procédé de préparation
US3546185A (en) 1968-03-20 1970-12-08 Monsanto Co Inhibiting premature vulcanization of diene rubbers
US5149798A (en) * 1989-04-06 1992-09-22 Worcester Foundation For Experimental Biology Process for synthesizing oligonucleotides and their analogs adaptable to large scale syntheses
CN1122137A (zh) * 1993-01-08 1996-05-08 海布里顿公司 二聚体块的合成及其在装配寡核苷酸中的应用
GB9501465D0 (en) 1995-01-25 1995-03-15 King S College London Nucleoside phosphorothioate derivatives,synthesis and use thereof
GB0004889D0 (en) * 2000-03-01 2000-04-19 Avecia Ltd Synthesis of oligonucleotides

Also Published As

Publication number Publication date
EA200000211A1 (ru) 2000-08-28
EP1325927A2 (en) 2003-07-09
ATE236916T1 (de) 2003-04-15
GB9717158D0 (en) 1997-10-22
DK1003758T3 (da) 2003-07-21
DE69813243D1 (de) 2003-05-15
EP1003758A2 (en) 2000-05-31
NZ502684A (en) 2002-12-20
IN190784B (enExample) 2003-08-23
HUP0002684A2 (hu) 2000-12-28
BR9811166A (pt) 2000-07-25
EP1003758B1 (en) 2003-04-09
ES2197491T3 (es) 2004-01-01
CN1274361A (zh) 2000-11-22
IL134517A0 (en) 2001-04-30
WO1999009041A2 (en) 1999-02-25
EP1325927A3 (en) 2008-07-02
US20030083490A1 (en) 2003-05-01
JP2001515086A (ja) 2001-09-18
PL338888A1 (en) 2000-11-20
US7019127B2 (en) 2006-03-28
HUP0002684A3 (en) 2001-11-28
DE69813243T2 (de) 2004-01-29
NO20000690L (no) 2000-04-11
AU8738698A (en) 1999-03-08
AU749343B2 (en) 2002-06-27
EA003091B1 (ru) 2002-12-26
KR20010022840A (ko) 2001-03-26
CN1231492C (zh) 2005-12-14
US6506894B1 (en) 2003-01-14
WO1999009041A3 (en) 1999-05-06
NO20000690D0 (no) 2000-02-11
US20050240015A1 (en) 2005-10-27
IL134517A (en) 2004-02-19
CA2300874A1 (en) 1999-02-25

Similar Documents

Publication Publication Date Title
TR200000384T2 (tr) Oligonükleotitlerin çözelti fazlı sentezi.
BR9814374A (pt) Inibição de quinase raf usando uréias heterocìclicas substituìdas
DE69840748D1 (de) Verfahren zur zubereitung von antisense oligonukleotiden
DK1054860T3 (da) Proces for syntesen af 1,3-dioler
EP1027473A4 (en) Mini-batch process chamber
DE69403642D1 (de) 7-deazapurin modifizierte oligonukleotide
EP1009860A4 (en) INHIBITION OF THE RAS GENE USING ANTISENSE OLIGONUCLEOTIDES
DE69835078D1 (de) Verfahren zur herstellung von polysilizium unter verwendung von exothermer reaktionswärme
DE69928667D1 (de) Nicht-peptide inhibitoren von vla-4 abhängiger zellbindung für die behandlung von entzündungen, autoimmune krankheiten und atemstörungen
DE60009665D1 (de) Zusammensetzungen zur behandlung von entzündungsreaktionen
BR0110402A (pt) Compostos
DE69609725D1 (de) Neue polymerträger zur nukleinsäuresynthese
DK1123414T3 (da) Antisense-modulering af integrin alpha 4.ekspression
ATE294186T1 (de) Verfahren zur herstellung von nukleotiden oder oligonukleotiden phosphoramitiden
DE69906856D1 (de) Methode für die Inhibition von Haarwuchs
DE69731112D1 (de) Verfahren zur synthese von phosphorothioat-oligonukelotiden
DE60204859D1 (de) Verfahren zur herstellung von 2'-fluoro-beta-l-arabinofuranosylnukleosiden
ATE335091T1 (de) Bc200 rna, daraus abgeleitete proben und entsprechende anwendungen
IT1312304B1 (it) Procedimento per rigenerare scoria di desolforazione.
DE59711973D1 (de) Vorrichtung zur Durchführung chemischer Reaktionsfolgen
ATE225363T1 (de) Synthese von morphin-6-glucuronid
EA200100987A1 (ru) Реагенты, содержащие бороновые кислоты, и олигонуклеотиды
DE59712270D1 (de) Verfahren zur kombination von paralleler oligonukleotidsynthese und darstellung von oligomer-chips
ES2137774T3 (es) Dispositivo y procedimiento para la sintesis de macromoleculas.
DE69906832D1 (de) Katalysatorzusammensetzung für die Hydrierung von olefinisch ungesättigten Verbindungen